Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Switching on cancer’s viral alarm system
19 May 2026
Publications
The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization
Journal article
Heirene L. et al, (2026), mAbs, 18
Image-based consensus molecular subtypes and colon cancer recurrence: Understanding the impact of lifestyle factors across subtypes of colon cancer
Journal article
Wesselink E. et al, (2026), Cancer Epidemiology, 103
The embryonic origins of site-specific arthritis
Journal article
Davidson S. et al, (2026), Nature Immunology
Seminars
Molecular recognition of the nucleosome by chromatin enzymes and factors
Friday, 26 June 2026, 11.15am to 12.15pm
Speaker(s): Prof Song Tan
conference
